US Bill Would Encourage Device Adverse-Event Reporting Experimentation
This article was originally published in SRA
US senators have introduced a bill that parallels medical device industry-friendly sections of the 21st Century Cures Act that cleared the House of Representatives last year, but also adds something new: a provision to give Food Drug Administration more flexibility to pilot alternatives to the current adverse-event report process.
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.